PubRank

Giulia Casorati

Author PubWeight™ 46.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High-frequency and adaptive-like dynamics of human CD1 self-reactive T cells. Eur J Immunol 2011 2.27
2 Invariant NKT cells sustain specific B cell responses and memory. Proc Natl Acad Sci U S A 2007 2.20
3 CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J Exp Med 2003 2.01
4 Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement. Nat Med 2002 1.80
5 Cutting edge: influence of the TCR Vbeta domain on the selection of semi-invariant NKT cells by endogenous ligands. J Immunol 2006 1.43
6 Dicer-dependent microRNA pathway controls invariant NKT cell development. J Immunol 2009 1.41
7 Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop. Eur J Immunol 2008 1.32
8 NKT-cell help to B lymphocytes can occur independently of cognate interaction. Blood 2008 1.28
9 Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma. Eur J Immunol 2003 1.25
10 Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions. Cytometry A 2008 1.24
11 Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4(+) T cell help. J Immunol 2012 1.22
12 T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification. Eur J Immunol 2002 1.14
13 Lipid-protein interactions: biosynthetic assembly of CD1 with lipids in the endoplasmic reticulum is evolutionarily conserved. Proc Natl Acad Sci U S A 2004 1.13
14 Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol 2004 1.12
15 Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells. J Immunol 2005 1.11
16 CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells. Blood 2007 1.09
17 Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development. J Exp Med 2008 1.08
18 Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. J Immunol 2004 1.07
19 The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function. J Exp Med 2009 1.06
20 Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice. J Immunol 2003 1.04
21 Fine tuning by human CD1e of lipid-specific immune responses. Proc Natl Acad Sci U S A 2011 0.98
22 Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia. Blood 2006 0.97
23 Innate-like effector differentiation of human invariant NKT cells driven by IL-7. J Immunol 2008 0.94
24 Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation. PLoS One 2013 0.94
25 Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells. J Immunol 2009 0.92
26 Invariant NKT cell reconstitution in pediatric leukemia patients given HLA-haploidentical stem cell transplantation defines distinct CD4+ and CD4- subset dynamics and correlates with remission state. J Immunol 2011 0.92
27 iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells. PLoS One 2010 0.91
28 Innate immune responses support adaptive immunity: NKT cells induce B cell activation. Vaccine 2003 0.91
29 CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope. Cancer Res 2003 0.91
30 Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules. Eur J Immunol 2008 0.88
31 Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer. Cancer Immunol Immunother 2014 0.86
32 Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptides. BMC Immunol 2005 0.86
33 iNKT-cell help to B cells: a cooperative job between innate and adaptive immune responses. Eur J Immunol 2014 0.84
34 Functional education of invariant NKT cells by dendritic cell tuning of SHP-1. J Immunol 2013 0.81
35 The CD4+ T-cell epitope-binding register is a critical parameter when generating functional HLA-DR tetramers with promiscuous peptides. Eur J Immunol 2010 0.81
36 MAGE-A3(161-175) contains an HLA-DRbeta4 restricted natural epitope poorly formed through indirect presentation by dendritic cells. Cancer Immunol Immunother 2007 0.78
37 On the use of donor-derived iNKT cells for adoptive immunotherapy to prevent leukemia recurrence in pediatric recipients of HLA haploidentical HSCT for hematological malignancies. Clin Immunol 2010 0.78
38 CD4+ T cell immunity against the human papillomavirus-18 E6 transforming protein in healthy donors: identification of promiscuous naturally processed epitopes. Eur J Immunol 2005 0.77
39 An efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinoma. PLoS One 2010 0.76
40 Peptidome from renal cell carcinoma contains antigens recognized by CD4+ T cells and shared among tumors of different histology. Clin Cancer Res 2006 0.76
41 An unexpected requirement for CD4+ T cells in anti-glycolipid antibody responses. Immunol Cell Biol 2011 0.75
42 B cell helper assays. Methods Mol Biol 2009 0.75